Table 3.
Physician Report on the Observed Effectiveness of Donepezil and Memantine Use among Patients with End-Stage Dementia, n = 152
| Donepezila% agree | Memantinea% agree | |
|---|---|---|
| Improves patient cognition | 10 | 10 |
| Stabilizes patient cognition | 22 | 23 |
| Decreases patient challenging behaviors | 28 | 25 |
| Helps maintain patient function | 22 | 19 |
| Provides palliation patient symptoms | 20 | 18 |
| Improves patient quality of life | 15 | 17 |
| Improves patient energy | 4 | 6 |
| Improves patient survival | 3 | 3 |
| Delays patient time to nursing home placement | 17 | 13 |
| Reduces time spent caregiving | 17 | 16 |
| Reduces caregiver burden | 20 | 18 |
| Improves caregiver quality of life | 20 | 16 |
| Is the standard of care | 17 | 16 |
a
Responses are collapsed from four-point Likert type scales (strongly agree, agree, disagree, strongly disagree) into dichotomous categories.